Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver

Cytotherapy

Volumn 16, Issue 6, 2014, Pages 800-809

  Bartlett, David C ^a   Hodson, James ^a   Bhogal, Ricky H ^a   Youster, Janine ^a   Newsome, Phil N ^a  

^a National Institute for Health Research Biomedical Unit and Centre for Liver Research University of Birmingham ^*  (United Kingdom)

Author keywords

Acetylcysteine; Cell transplantation; Hepatocytes; Liberase

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; COLLAGENASE; LIBERASE; UREA; THERMOLYSIN;

ADULT; AGED; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL ISOLATION; CELL METABOLISM; CELL STRUCTURE; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATION PERFUSION; LIVER CELL; LIVER PERFUSION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MONOLAYER CULTURE; PERFUSION; PERFUSION TIME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCORING SYSTEM; UNITED KINGDOM END STAGE LIVER DISEASE SCORE; UREA CYCLE; CELL SURVIVAL; DRUG EFFECTS; LIVER; METABOLISM; PANCREAS ISLET; PATHOLOGY; PROCEDURES; TRANSPLANTATION;

ACETYLCYSTEINE; CELL SURVIVAL; COLLAGENASES; HEPATOCYTES; HUMANS; ISLETS OF LANGERHANS; LIVER; THERMOLYSIN; TRANSPLANTATION;

EID: 84899921179     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.01.006     Document Type: Article

References (40)

1. Houlihan D.D., Newsome P.N. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008, 135:438-450.
2. Forbes S.J., Newsome P.N. New horizons for stem cell therapy in liver disease. J Hepatol 2012, 56:496-499.
3. Piscaglia A.C., Campanale M., Gasbarrini A., Gasbarrini G. Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int 2010, 2010:259461.
4. Siniscalco D., Pandolfi A., Galderisi U. State-of-the-art on basic and applied stem cell therapy: Stem Cell Research Italy-International Society for Cellular Therapy Europe, Joint Meeting, Montesilvano (PE) Italy, June 10-12, 2011. Stem Cells Dev 2012, 21:668-669.
5. Oertel M., Shafritz D.A. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008, 1782:61-74.
6. Thomas J.A., Forbes S.J. A fat chance for hepatocyte transplantation?. Gut 2009, 58:480-482.
7. Strom S., Fisher R. Hepatocyte transplantation: new possibilities for therapy. Gastroenterology 2003, 124:568-571.
8. Lo B., Parham L. Ethical issues in stem cell research. Endocr Rev 2009, 30:204-213.
9. Tsiaoussis J., Newsome P.N., Nelson L.J., Hayes P.C., Plevris J.N. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transplant 2001, 7:2-10.
10. Fitzpatrick E., Mitry R.R., Dhawan A. Human hepatocyte transplantation: state of the art. J Intern Med 2009, 266:339-357.
11. Dhawan A., Strom S.C., Sokal E., Fox I.J. Human hepatocyte transplantation. Methods Mol Biol 2010, 640:525-534.
12. Puppi J., Strom S.C., Hughes R.D., Bansal S., Castell J.V., Dagher I., et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 2012, 21:1-10.
13. Dhawan A., Puppi J., Hughes R.D., Mitry R.R. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010, 7:288-298.
14. Li A.P. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 2007, 168:16-29.
15. LeCluyse E.L., Alexandre E. Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol Biol 2010, 640:57-82.
16. Alexandrova K., Griesel C., Barthold M., Heuft H.G., Ott M., Winkler M., et al. Large-scale isolation of human hepatocytes for therapeutic application. Cell Transplant 2005, 14:845-853.
17. Hughes R.D., Mitry R.R., Dhawan A., Lehec S.C., Girlanda R., Rela M., et al. Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transplant 2006, 12:713-717.
18. Kawahara T., Toso C., Douglas D.N., Nourbakhsh M., Lewis J.T., Tyrrell D.L., et al. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transplant 2010, 16:974-982.
19. Vondran F.W., Katenz E., Schwartlander R., Morgul M.H., Raschzok N., Gong X., et al. Isolation of primary human hepatocytes after partial hepatectomy: criteria for identification of the most promising liver specimen. Artif Organs 2008, 32:205-213.
20. Bhogal R.H., Hodson J., Bartlett D.C., Weston C.J., Curbishley S.M., Haughton E., et al. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 2011, 6:e18222.
21. Berry M.N., Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 1969, 43:506-520.
22. Linetsky E., Selvaggi G., Bottino R., Kong S.S., Qian T., Alejandro R., et al. Comparison of collagenase type P and Liberase during human islet isolation using the automated method. Transplant Proc 1995, 27:3264.
23. Linetsky E., Bottino R., Lehmann R., Alejandro R., Inverardi L., Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997, 46:1120-1123.
24. Brandhorst H., Brandhorst D., Hering B.J., Bretzel R.G. Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion. Transplantation 1999, 68:355-361.
25. Donini A., Baccarani U., Lavaroni S., Dialti V., Adami V., Risaliti A., et al. Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation. Transplant Proc 2001, 33:1972-1973.
26. Atkinson M.C. The use of N-acetylcysteine in intensive care. Crit Care Resusc 2002, 4:21-27.
27. Zwingmann C., Bilodeau M. Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology 2006, 43:454-463.
28. Dunne J.B., Davenport M., Williams R., Tredger J.M. Evidence that S-adenosylmethionine and N-acetylcysteine reduce injury from sequential cold and warm ischemia in the isolated perfused rat liver. Transplantation 1994, 57:1161-1168.
29. Fukuzawa K., Emre S., Senyuz O., Acarli K., Schwartz M.E., Miller C.M. N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 1995, 59:6-9.
30. Fusai G., Glantzounis G.K., Hafez T., Yang W., Quaglia A., Sheth H., et al. N-acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci 2005, 109:465-473.
31. Sagias F.G., Mitry R.R., Hughes R.D., Lehec S.C., Patel A.G., Rela M., et al. N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant 2010, 19:1487-1492.
32. Pichard L., Raulet E., Fabre G., Ferrini J.B., Ourlin J.C., Maurel P. Human hepatocyte culture. Methods Mol Biol 2006, 320:283-293.
33. Laba A., Ostrowska A., Patrzalek D., Paradowski L., Lange A. Characterization of human hepatocytes isolated from non-transplantable livers. Arch Immunol Ther Exp 2005, 53:442-453.
34. NHS Blood and Transplant. Transplant Activity in the UK. 2011 June 19 [cited 2012 Jul 4]. Available from: URL: http://www.organdonation.nhs.uk/ukt/statistics/transplant_activity_report/transplant_activity_report.asp.
35. Georges P., Muirhead R.P., Williams L., Holman S., Tabiin M.T., Dean S.K., et al. Comparison of size, viability, and function of fetal pig islet-like cell clusters after digestion using collagenase or liberase. Cell Transplant 2002, 11:539-545.
36. Dolmans M.M., Michaux N., Camboni A., Martinez-Madrid B., Van L.A., Nottola S.A., et al. Evaluation of Liberase, a purified enzyme blend, for the isolation of human primordial and primary ovarian follicles. Hum Reprod 2006, 21:413-420.
37. Pinkse G.G., Voorhoeve M.P., Noteborn M., Terpstra O.T., Bruijn J.A., De H.E. Hepatocyte survival depends on beta1-integrin-mediated attachment of hepatocytes to hepatic extracellular matrix. Liver Int 2004, 24:218-226.
38. Rosner G., Oren R., Halpern Z., Zvibel I. Anoikis mechanisms during hepatocyte isolation. Hepatology 2002, 36:467A.
39. Zvibel I., Smets F., Soriano H. Anoikis: roadblock to cell transplantation?. Cell Transplant 2002, 11:621-630.
40. Greuet J., Pichard L., Ourlin J.C., Bonfils C., Domergue J., Le T.P., et al. Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture. Hepatology 1997, 25:1166-1175.